Summary: Researchers have found nine blood-based microRNAs that are more common in teenagers diagnosed with depression, which could serve as an early detection biomarker. Interestingly, these molecules aren’t present in cases of depression in adults, hinting at distinct biological processes in adolescents.
This study employed a minimally invasive technique using dried blood spots, making it feasible for widespread screening. Such a development may facilitate more objective and timely diagnoses of adolescent depression before symptoms escalate or become resistant to treatment.
Key Facts:
- Unique Biomarkers: Nine microRNAs linked to depression in teens were absent in adult cases.
- Minimally Invasive Testing: Blood samples obtained from finger pricks allow for easy, long-term collection.
- Early Detection Potential: These biomarkers may help identify at-risk teenagers before they show clinical symptoms.
Using an innovative lab method, researchers from McGill University discovered nine elevated molecules in the blood of depressed adolescents. These molecules also indicate how symptoms may progress over time.
This clinical study’s findings could lead to earlier diagnoses, potentially preventing the worsening of symptoms that are harder to treat.
“Alarmingly, an increasing number of adolescents are being diagnosed with depression, and early onset can lead to long-lasting and severe consequences,” noted Cecilia Flores, a senior researcher at McGill. “Those with depression in their teen years often face challenges like substance use and social isolation, and their symptoms frequently don’t respond well to treatment.”
The focus of the study included 62 teenagers: 34 diagnosed with depression and 28 without. Blood samples were collected, allowed to dry, and then frozen to maintain consistency. The simplicity of taking samples from a finger prick makes this method practical for wider application.
First author Alice Morgunova remarked, “Our results highlight the potential of dried blood spots as a practical tool in psychiatry, enabling us to monitor early biological changes related to mental health with a less invasive technique.”
Current diagnoses of depression largely depend on self-reported symptoms, which isn’t always reliable—especially if teenagers are uncertain about their feelings or hesitant to share them. A blood-based screening method could add an objective way to identify at-risk teens.
The research team plans to validate these findings with larger groups and further explore how these microRNAs interact with both genetic and environmental risk factors.
About the study
“Peripheral microRNA signatures in adolescent depression” by Alice Morgunova and Cecilia Flores et al., was published in Biological Psychiatry Global Open Science.
Funding: This study received support from various organizations, including the Douglas Foundation, NIH, and Canadian research institutes.
About this research on depression and genetics
Abstract: Adolescent depression correlates with long-term negative outcomes, and there’s an urgent need to identify signs for early intervention. MicroRNAs, which influence adolescent neurodevelopment, could serve as potential markers, yet their role in depression is largely unexplored.
The study analyzed microRNA profiles from dried blood samples of both depressed and healthy adolescents. By sequencing these samples, the researchers identified nine microRNAs with altered expressions that could indicate future neurobiological issues.
This research sets the stage for identifying microRNA markers in adolescents that may inform future understanding of mental health risks throughout life.
